Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
FRONTIERS IN ONCOLOGY（2021）
Key words
drug repositioning,resistant cancer,P-gp overexpresssion,MDR,anticancer drug,molecular targeting,lower toxicity,cancer stem cell
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined